ArticleACS applied polymer materials2026
Designing Macrovoid-Free Polysulfone (PSf) Ultrafiltration (UF) Membranes with Tetraoxaundecane (TOU) Solvent.
Article in ACS applied polymer materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Formation of macrovoids in the membrane structure is a common occurrence in the process of nonsolvent-induced phase separation (NIPS), yet it is often undesired due to low structural homogeneity, poor performance, and introduction of weak mechanical points. Here, we introduce an ether-based solvent, 2,5,7,10-tetraoxaundecane (TOU), for fabrication of macrovoid-free polysulfone (PSf) ultrafiltration (UF) membranes. We investigate how strong polymer-solvent affinity, high chain entanglement, and high viscosity influence the phase-inversion process and promote the formation of homogeneous membrane structures during NIPS. Membranes prepared from PSf/TOU dope solutions exhibited stable sponge-like morphology, without macrovoids, in contrast to PSf membranes prepared from the more common solvent
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.